Centro Médico Teknon
| Turquia | Áustria | Espanha | |
| Terapia de radiação para o cancro colorretal | de $7,000 | de $12,000 | de $10,000 |
| Terapia de Radiação para Sarcomas | de $3,250 | de $18,000 | de $8,000 |
| Remoção de rabdomiossarcoma | de $15,000 | de $30,000 | de $35,000 |
| Quimioterapia para cancro da mama | de $1,200 | de $15,000 | de $3,500 |
| Tratamento complexo do rabdomiossarcoma | de $45,000 | - | - |
O Dr. Graupera é um oncologista pediátrico premiado, especializado em sarcomas ósseos e de tecidos moles no SJD Barcelona Children's Hospital – um dos melhores da Europa.
Diretor da Unidade de Hematologia e Oncologia Pediátrica do HM Montepríncipe – O Dr. Lopez Ibor é especialista no tratamento de tumores ósseos e cerebrais em crianças e adolescentes.
A Dra. Blanca Lopez Ibor lidera a Unidade de Hematologia e Oncologia Pediátrica do HM Hospitales, com mais de 30 anos de experiência em oncologia pediátrica.
O médico é oncologista pediátrico com 37 anos de experiência, especializado no tratamento de distúrbios sanguíneos e na realização de procedimentos como transplantes de medula óssea e terapia de ablação. Atualmente, o médico é Chefe de Hemato-Oncologia Pediátrica no Hospital Universitário Quironsalud Madrid.<\/p>
Com um histórico acadêmico prolífico, o médico editou 14 livros, contribuiu para 75 capítulos de livros e apresentou em mais de 200 conferências. O médico é membro de várias associações profissionais, incluindo a Associação Espanhola de Hematologia Pediátrica e a Associação Espanhola de Oncologia Pediátrica.<\/p>
O médico trata uma ampla gama de condições, incluindo leucemia, linfoma, mieloma múltiplo e vários distúrbios hematológicos e autoimunes.<\/p>
Spanish hospitals such as SJD Barcelona Children’s Hospital and Clinica Universidad de Navarra specialize in rhabdomyosarcoma. These centers offer advanced molecular diagnostics and proton therapy within JCI-accredited facilities. Specialized pediatric oncologists focus on limb-preserving surgeries and targeted therapy for rare pediatric soft tissue sarcomas.
Bookimed Expert Insight: Quality signals for rare sarcomas are often found in the clinic's research capacity and patient volume. While Centro Médico Teknon serves 10,000 patients annually with JCI-certified care, SJD Barcelona treats 450,000 patients and maintains a dedicated molecular laboratory. This volume allows surgeons like Dr. Jaume Mora Graupera to manage complex cases that smaller facilities rarely see.
Patient Consensus: Families emphasize that traveling to a tertiary referral center is vital for rare tumors. They note that having a multidisciplinary tumor board and a specialist pathology review provides much-needed peace of mind during diagnosis.
Standard treatment options in Spanish clinics include multimodal approaches combining surgery, chemotherapy, and high-precision radiation. Specialized centers utilize diagnostic tools like PET-CT and MRI to stage sarcomas. Facilities often prioritize function preservation using targeted proton therapy and robotic-assisted tumor resections within JCI-accredited hospitals.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra report exceptional success with a 95% limb preservation rate for sarcomas. This outcome stems from a multidisciplinary approach where surgeons and oncologists prioritize saving function alongside cancer control. Choosing a certified sarcoma center in Spain is vital for rare diagnoses. These facilities often provide access to clinical trials and advanced proton beam therapy, which are not available in standard general hospitals.
Patient Consensus: Patients emphasize the importance of starting with chemotherapy to reduce tumor size before any surgery. They often note that a long surveillance period with repeated scans is the most challenging physical and emotional phase of recovery.
Relapsed or refractory rhabdomyosarcoma is treated with salvage chemotherapy, surgical resection, and radiation therapy. Spanish oncology centers frequently utilize regimens like Vincristine, Irinotecan, and Temozolomide. Specialist centers like SJD Barcelona Children Hospital also offer clinical trials and molecularly targeted immunotherapy for advanced cases.
Bookimed Expert Insight: Spain stands out for pediatric sarcoma care because of the high concentration of JCI-accredited centers in Barcelona and Madrid. For example, Clinica Universidad de Navarra reports a 95% limb preservation rate. This suggests that Spanish specialists prioritize functional recovery alongside tumor removal. When choosing a clinic, patients should look for those like SJD Barcelona Children Hospital that integrate active molecular research labs into their clinical practice.
Patient Consensus: Patients emphasize the need for a full record of prior treatments since previous radiation limits current options. They note that survival goals must be clarified early to choose between aggressive trial therapies or symptom-focused care.
Proton therapy provides precise radiation by eliminating the exit dose in healthy tissue. This technology protects developing organs in growing children. It significantly reduces long-term complications for tumors in sensitive areas like the head or pelvis. Treatment preserves growth, vision, and cognitive functions.
Bookimed Expert Insight: While Spain has 83 medical centers, specialized pediatric oncology and proton therapy are concentrated in specific hubs. Clinica Universidad de Navarra is a leading sarcoma center with a 95% limb preservation rate. Families should verify if tumors near the optic nerve or brain are eligible for the Proton Therapy Centre Quironsalud in Madrid. This facility specifically focuses on research-driven innovation to minimize late-stage side effects in children.
Patient Consensus: Patients note it is important to ask which specific late effects protons might reduce. They emphasize that while cure rates are similar to standard therapy, the primary goal is protecting quality of life decades later.
Spanish surgical teams achieve 95% limb preservation rates for complex sarcoma cases. Specialist centers prioritize multidisciplinary protocols to avoid amputation while ensuring clear margins. These outcomes are supported by advanced diagnostics like PET-CT and the integration of highly specialized pediatric and adult oncology units.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra and SJD Barcelona Children’s Hospital function as specialized hubs where high patient volumes drive better outcomes. Our data shows Clinica Universidad de Navarra serves over 140,000 patients yearly. This concentration of expertise allows surgeons to perform limb-sparing procedures even when tumors are near major nerves or vessels.
Patient Consensus: Patients note that limb preservation is most successful when tumors respond well to initial therapy. They emphasize that while function is saved, long-term rehabilitation is often necessary to manage stiffness.
Treatment planning for international pediatric patients involves a structured remote evaluation before travel. Specialized Spanish oncology centers review medical dossiers to determine clinical feasibility. A multidisciplinary tumor board then outlines a preliminary care pathway. This process ensures medical and logistics readiness for the child.
Bookimed Expert Insight: Spanish pediatric centers like SJD Barcelona Children’s Hospital often require pathology slide reviews. This step is critical for rhabdomyosarcoma to confirm tumor subtypes before travel. Clinica Universidad de Navarra reports a 95% limb preservation rate for sarcomas. This suggests their planning focus heavily prioritizes functional outcomes through specialized surgical techniques.
Patient Consensus: Parents emphasize that the first phase involves diagnostic confirmation before therapy begins. They note the importance of sending all imaging and records early to avoid treatment delays.